In addition to sustained weight loss, long-term use is associated with continued cardiovascular protection, maintained glycemic control, and progressive improvements in metabolic markers
When prescribed and monitored by a qualified medical provider, it is considered a safe treatment option for many individuals seeking medical weight loss support
Patients and clinicians are encouraged to monitor updates from the MHRA, EMA, and NICE as the evidence base for retatrutide continues to develop, and to rely on authoritative sources including the MHRA website, NICE guidance, and peer-reviewed trial publications rather than anecdotal reports when making treatment decisions
Should peptides be stored in the fridge or freezer
Patient Support and Education: Novo Nordisk has initiated or expanded patient support programs, providing educational materials, support lines, and resources to help users understand and manage potential side effects